NEUROONE MEDICAL TECHNOLOGIE (NMTC)
US64130M2098 - Common Stock
| TTM (2024-3-31) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | 2020 (2020-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -12.80M | -11.86M | -10.00M | -9.95M | -13.64M | |||
| Depreciation Amortization | 238.83K | 199.27K | 120.00K | 80.00K | 50.00K | |||
| Change In Working Capital | -636.46K | -2.43M | 1.21M | -510.00K | -430.00K | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 1.38M | 1.20M | 1.15M | 1.78M | 10.60M | |||
| OPERATING CASH FLOW | -11.83M | -12.89M | -7.52M | -8.60M | -3.43M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -262.61K | -384.12K | -280.00K | -70.00K | -120.00K | |||
| Other Investing Activity | 1.00M | 3.03M | -2.97M | N/A | N/A | |||
| INVESTING CASH FLOW | 741.47K | 2.65M | -3.24M | -70.00K | -120.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 8.83M | |||
| Stock Issued/Repurchased | 10.97M | 8.47M | 13.35M | 12.79M | 0.00 | |||
| Other Financing Activity | -1.05M | -1.07M | -1.33M | -1.25M | -1.51M | |||
| FINANCING CASH FLOW | 9.91M | 7.40M | 12.02M | 11.53M | 7.32M | |||
| CHANGE IN CASH | -1.18M | -2.84M | 1.26M | 2.86M | 3.77M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -11.83M | -12.89M | -7.52M | -8.60M | -3.43M | |||
| Capital Expenditure | -262.61K | -384.12K | -280.00K | -70.00K | -120.00K | |||
| FREE CASH FLOW | -12.09M | -13.27M | -7.80M | -8.67M | -3.55M | |||
All data in USD